EUVIMEDEUVIMED entdecken
Open Access

Identifying Varying Influences on Eliminating Hepatitis C Across Medical Specialties

Christopher J Gonzalez iD, Clarence N Perez-Mejia, Noelia Hernandez, Shashi N Kapadia iD, Jeff Niederdeppe iD, Arpan Dharia, Zoi Papalamprakopoulou, Andrew H Talal, Audrey R Lloyd, Ricardo Franco, Martin F Shapiro, Elaine Wethington

Journal of Viral Hepatitis · 2025

DOI: 10.1111/jvh.70093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2025. Verfasst von Christopher J Gonzalez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Hepatitis C, Health Personnel, Disease Eradication. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIDA NIH HHS, Kaleida Health Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective:To identify specialty‐specific influences in administering HCV treatment among primary care, gastroenterology/hepatology, infectious diseases, and addiction specialties, and strategies to potentially eliminate HCV. Study Setting and Design:Qualitative study using remote interviews with healthcare providers in New York and Alabama who treated or screened patients for HCV, purposefully sampling for specialty, clinical setting, and HCV treatment experience. Data sources and Analytic Sample: Interviews occurred 9/2021–8/2022. Transcripts were analyzed using a hybrid inductive‐deductive approach; a content analysis identified codes arising uniquely within specialties. Results: Thirty‐six providers were interviewed: primary care ( n = 9), addiction medicine ( n = 12), infectious diseases ( n = 9), and gastroenterology/hepatology ( n = 6). Distinct challenges and facilitators emerged across specialties. Primary care and addiction providers similarly emphasized the convenience and usual practice of referring patients to specialists for HCV treatment, while infectious disease and gastroenterology noted challenges with patients not completing the referrals. Primary care providers expressed wanting training and peer support related to treatment provision. Addiction providers described structural barriers, such as lacking on‐site phlebotomy services and patients' competing health concern prioritization, but highlighted strategies to improve treatment access, including trust‐building. Infectious disease providers highlighted using patient navigators to overcome logistical barriers, while gastroenterologists emphasized collaborative relationships, particularly with addiction specialists. Specialty‐specific opportunities emerged regarding training, collaboration, navigation, and infrastructure. Conclusions:Eliminating HCV requires addressing specialty‐specific concerns for providers managing HCV. Potential opportunities include dissemination of specialty‐tailored training, facilitating interdisciplinary care and desired cross‐specialty collaborations, and overcoming unique infrastructural needs. Future research should evaluate implementation strategies addressing these specialty‐specific needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis CHealth PersonnelDisease EradicationHumansNew YorkMalePrimary Health CareQualitative ResearchFemaleAlabamaMiddle AgedAdultInterviews as TopicReferral and Consultation

Stichwörter der Autor:innen

barriersfacilitatorshepatitis cprimary carespecialty

Autor:innen und Institutionen

  • Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
  • Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, USA.
  • Cornell Jeb E. Brooks School of Public Policy and Department of Communication, Cornell University, Ithaca, New York, USA.
  • Division of Gastroenterology, Hepatology and Nutrition, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
  • Department of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Department of Medicine, Miller School of Medicine, Miami, Florida, USA.

ORCID-Profile: Christopher J Gonzalez, Shashi N Kapadia, Jeff Niederdeppe

Förderung

  • NCATS NIH HHS
  • NIDA NIH HHS
  • Kaleida Health Foundation
  • NIDDK NIH HHS
  • Patient-Centered Outcomes Research Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute on Drug Abuse

Zitieren

APA

Gonzalez, C. J., Perez-Mejia, C. N., Hernandez, N., Kapadia, S. N., Niederdeppe, J., Dharia, A., Papalamprakopoulou, Z., Talal, A. H., Lloyd, A. R., Franco, R., Shapiro, M. F., & Wethington, E. (2025). Identifying Varying Influences on Eliminating Hepatitis C Across Medical Specialties. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.70093

Vancouver

Gonzalez CJ, Perez-Mejia CN, Hernandez N, Kapadia SN, Niederdeppe J, Dharia A, et al. Identifying Varying Influences on Eliminating Hepatitis C Across Medical Specialties. Journal of Viral Hepatitis. 2025. doi:10.1111/jvh.70093

BibTeX
@article{Gonzalez2025,
  author = {Gonzalez, Christopher J and Perez-Mejia, Clarence N and Hernandez, Noelia and Kapadia, Shashi N and Niederdeppe, Jeff and Dharia, Arpan and Papalamprakopoulou, Zoi and Talal, Andrew H and Lloyd, Audrey R and Franco, Ricardo and Shapiro, Martin F and Wethington, Elaine},
  title = {Identifying Varying Influences on Eliminating Hepatitis C Across Medical Specialties},
  journal = {Journal of Viral Hepatitis},
  year = {2025},
  doi = {10.1111/jvh.70093}
}
Kostenlos starten →